Skip to main content
. 2022 Mar 4;12:764571. doi: 10.3389/fendo.2021.764571

Figure 2.

Figure 2

Nomogram for predicting 3- and 5-year overall survival (OS) (A) and cancer-specific survival (CSS) (B) for synovial sarcoma (SyS) patients.